Disclosures for "Compound Muscle Action Potential (CMAP) Duration and Myosin Loss in Patients with Critical Illness Myopathy: Correlation and Prognostication"
-
Dr. Shelly has nothing to disclose.
-
The institution of Dr. Soontrapa has received research support from Argenx.
-
Dr. Madigan has nothing to disclose.
-
Mr. Polzin has nothing to disclose.
-
Dr. Singh has nothing to disclose.
-
Dr. Sista has nothing to disclose.
-
Dr. Paul has nothing to disclose.
-
Dr. Liao has nothing to disclose.
-
Dr. Braksick has nothing to disclose.
-
Dr. Boon has received personal compensation in the range of $500-$4,999 for serving as a Consultant for HPE cosmetics .
-
Dr. Litchy has nothing to disclose.
-
Dr. Milone has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Milone has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Genetics, AAN. The institution of Dr. Milone has received research support from Mayo Clinic, CCaTS-CBD. The institution of Dr. Milone has received research support from Mayo Clinic, SGP Award. The institution of Dr. Milone has received research support from MDA for Care Center grant. The institution of Dr. Milone has received research support from Regenerative medicine Minnesota.
-
Dr. Liewluck has nothing to disclose.